logo
Bacteria in your mouth might reveal how depressed you are, scientists say

Bacteria in your mouth might reveal how depressed you are, scientists say

Yahoo14 hours ago

Depression could be linked to a lack of diversity in the bacteria in your mouth, according to new research.
As you read this, your mouth contains between 500 billion and 1 trillion bacteria. After the gut microbiome, the orifice is the second-largest community of microorganisms in human bodies.
Now, researchers at New York University say the makeup of those microbes could be used to help diagnose and treat depression. In a new study, they found that less diversity of microbes in the mouth is associated with the mental health condition.
'It's possible that the oral microbiome influences depressive symptoms through inflammation or changes to the immune system. Conversely, depression can drive changes including dietary intake, poor oral hygiene, increased smoking and drinking, or the use of medications—all of which have the potential to alter the oral microbiome,' Dr. Bei Wu, vice dean for research at NYU Rory Meyers College of Nursing, said in a statement. 'We need more research to understand the direction and underlying pathways of this relationship.'
Wu is the senior author of the study, which was published this week in the journal BMC Oral Health.
To reach these conclusions, the authors examined data from the Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey. They used questionnaire data from more than 15,000 adults collected between 2009 and 2012 to compare symptoms of depression with saliva samples.
They also used gene sequencing to identify the microbes in the saliva and measure the diversity of the oral microbiome. That's how they found that people with less microbial diversity were more likely to have symptoms of depression.
Additional analysis revealed that practices including smoking, drinking, and dental care influenced the relationship between the oral microbiome and depression. They can all change the makeup of bacteria in the mouth.
They noted that antidepressants and other psychotropic medications have side effects that can lead to reduced saliva and alter the oral microenvironment.
'Thus, medications not only alleviate depressive symptoms but also have a regulatory effect on oral health,' they said.
Still, it remains unclear whether the diversity of microbes in the mouth influences depression, if depression leads to changes in the oral microbiome, or if there's a symbiotic relationship.
They noted that a recent study found a potential link between depression and the diversity of bacteria in the gut, and that a growing body of research points to a connection between the oral microbiome and overall health. That's thought to be driven by inflammation and disruptions to the immune system.
They hope these findings will support a greater understanding of the issue. In 2021, an estimated 21 million adults had at least one major depressive episode in the past year.
'Having a better understanding of the relationship between the oral microbiome and depression could not only help us learn about the mechanisms underlying depression, but could contribute to the development of new biomarkers or treatments for mood disorders,' said Wu.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Scarlett Johansson Details Depths of Her ‘Jurassic Park' Fandom, From Pitching Herself to Steven Spielberg to Organizing Screening for Avengers Cast
Scarlett Johansson Details Depths of Her ‘Jurassic Park' Fandom, From Pitching Herself to Steven Spielberg to Organizing Screening for Avengers Cast

Yahoo

time19 minutes ago

  • Yahoo

Scarlett Johansson Details Depths of Her ‘Jurassic Park' Fandom, From Pitching Herself to Steven Spielberg to Organizing Screening for Avengers Cast

Scarlett Johansson loves Jurassic Park so much that she had no issue pitching herself to franchise guru Steven Spielberg when she got word that a new installment was in the works. But she did have a dilemma: Play it cool or go full fangirl? 'I had a meeting with him and I don't actually know if he knew the depths of my Jurassic fandom, but I'm hoping that no one explained it to him too thoroughly because it maybe would've come off as being a little too much,' Johansson explained to The Hollywood Reporter during a recent interview about her Cannes Film Festival selection Eleanor the Great. 'Although knowing Steven now, he was excited when I shared with how much it would mean to me to play any part in Jurassic. I could've played it cooler and maybe I wouldn't have gotten it.' More from The Hollywood Reporter 'Music by John Williams' Doc Director on How Spielberg Convinced the Legendary Composer to Do the Film Scarlett Johansson's 'Eleanor the Great' Draws Cheers, Tears at Cannes Premiere 'Eleanor the Great' Review: June Squibb Steadies Scarlett Johansson's Wobbly Directorial Debut Got it she did, and audiences will soon have the chance to see the fangirl-turned-franchise star when Universal Pictures' Jurassic World Rebirth hits theaters on July 2. The entry marks a new era in the Jurassic Park universe and finds Johansson starring opposite a cast that includes Jonathan Bailey, Mahershala Ali, Rupert Friend, Manuel Garcia-Rulfo, Luna Blaise, David Iacono, Audrina Miranda, Philippine Velge, Bechir Sylvain and Ed Skrein. Directed by Gareth Edwards from a script by David Koepp, Jurassic World Rebirth picks up five years after the events of Jurassic World Dominion at a time when the planet's ecology has proven largely inhospitable to dinosaurs. Those remaining exist in isolated equatorial environments with climates resembling the one in which they once thrived. The three most colossal creatures across land, sea and air within that tropical biosphere hold, in their DNA, the key to a drug that will bring miraculous life-saving benefits to humankind. Johansson stars as Zora Bennett, a covert operations expert who is contracted to lead a skilled team on a top-secret mission to secure the genetic material. When Zora's operation intersects with a civilian family whose boating expedition was capsized by marauding aquatic dinos, they all find themselves stranded on a forbidden island that had once housed an undisclosed research facility for Jurassic Park. 'Unbelievable' is how Johansson describes the fact that she's in the new installment. 'I've been trying to get into a Jurassic movie for, I don't know, 15 years or something,' she continued. 'I was so stoked that it all came together.' Like most things in Hollywood, it all came down to timing. 'When I first heard that there was a new Jurassic movie coming, that it was written with a female lead who was the age that I could fit into, and that it was happening during a time period that I could shoot, it was particularly surreal,' Johansson said. 'I was actually in the middle of making Eleanor — we were filming it at the time — so there was a lot happening at the time. I had to compartmentalize my nervous excitement for the job in front of me while also focusing on making it work. I would have these really geeked out, fangirl moments and then be, like, 'OK, put that away for a second.'' Johansson's fandom dates back to the release of the original Jurassic Park in the summer of 1993. She was only 8 years old at the time, and on the verge of making her big screen debut in North. 'It was such a formative moviegoing experience for me. It was like nothing any of us had seen before. The effects were extraordinary. It was the perfect mix of CGI, puppetry, an incredible score, a mix of drama with some comedy, it was gory but not too gory, it was scary but not too scary. The kids were great in it. It hit every part of what makes a movie great in a theater, and it felt like everyone was having such a collective experience. It was so thrilling and has stayed with me forever. Those kinds of movies are rare, and I'm here for them. I'm here to be carried away, entertained and thrilled.' She's become such an obsessed fan that when the first Jurassic World film came out in 2015, she happened to be on a job with her Marvel Cinematic Universe colleagues so she organized a group outing. 'I love to go to these movies with total abandon, grab a huge bucket of popcorn and some Raisinets and just disappear into the film. I'm such a fan,' she said. 'When the new Jurassic World came out, we were in New Mexico filming one of the Avengers films, and I set up this weekend outing. We took a big group and ate chicken fingers and nachos and yelled at the screen. I was so pumped that there was a new generation of Jurassic. Now that I get to be in one, it's just crazy.' And she learned a lesson along the way: 'It taught me that if you are enthusiastic about a project, it is actually good to share your enthusiasm. You don't have to dumb it down or play it cool.'Best of The Hollywood Reporter 13 of Tom Cruise's Most Jaw-Dropping Stunts Hollywood Stars Who Are One Award Away From an EGOT 'The Goonies' Cast, Then and Now

Anne Wojcicki's nonprofit wins bid to acquire genetic testing company 23andMe
Anne Wojcicki's nonprofit wins bid to acquire genetic testing company 23andMe

CNN

time20 minutes ago

  • CNN

Anne Wojcicki's nonprofit wins bid to acquire genetic testing company 23andMe

A nonprofit led by Anne Wojcicki, the co-founder and former chief executive of 23andMe, won a bid to acquire the genetic testing company following its bankruptcy filing in March. Wojcicki's California-based nonprofit, TTAM Research Institute, will purchase 23andMe for $305 million, according to a news release on Friday. It's the final twist in the bidding war between TTAM and Regeneron Pharmaceuticals, which announced on May 19 that it would buy most of 23andMe's assets for $256 million. The Wall Street Journal reported that New York-based Regeneron cited 'its assessment of 23andMe's remaining value' for not submitting a higher bid. 23andMe and Regeneron did not respond to CNN's request for comment. Wojcicki stepped down from 23andMe on March 24, when the company filed for Chapter 11 bankruptcy. 23andMe's struggles drew attention in September 2024 when all seven of the company's independent directors resigned en masse, citing frustration with Wojcicki's 'strategic direction' and efforts to take the company private. In November 2024, 23andMe cut about 40% of its workforce, or roughly 200 employees, and discontinued developments of its therapies in a restructuring effort. 23andMe, which at one point was valued at $6 billion, has collected genetic data from 15 million customers through at-home DNA testing kits that used saliva samples. The testing kits offered 'personalized genetic insights' that could flag potential health risks. But 23andMe struggled to convert one-time buyers into subscribers. The company's bankruptcy filing sparked concern about data privacy, as customers worried their genetic information would be sold to a third party. Twenty-seven states and the District of Columbia filed a lawsuit on Monday against 23andMe to block the sale of genetic data without customer consent. Interested companies could use 23andMe's data to personalize their products or advertising. Genetics can be linked to food preferences, for instance. Genetic data could also be used when developing personalized medicine, Gideon Nave, an associate professor of marketing at the University of Pennsylvania's Wharton School, told CNN in March. There aren't many restrictions in place to prevent genetic discrimination, although the Genetic Information Nondiscrimination Act prevents gene information from being used for discrimination in health insurance coverage or employment. According to the news release, TTAM said that it will comply with 23andMe's privacy policies and honor existing policies regarding customer data rights, such as deleting accounts and opting out of research. 'I am thrilled that TTAM Research Institute will be able to continue the mission of 23andMe to help people access, understand and benefit from the human genome. We believe it is critical that individuals are empowered to have choice and transparency with respect to their genetic data and have the opportunity to continue to learn about their ancestry and health risks as they wish,' Wojcicki said in a news release. TTAM, an acronym for the first letters of 23andMe, will acquire 'substantially all' of 23andMe's assets, including its personal genome service, research services and Lemonaid Health, a telehealth program acquired by the company in 2021. The deal still needs to be approved by the US Bankruptcy Court for the Eastern District of Missouri. A hearing is scheduled for June 17, according to the release. CNN's Lisa Eadicicco contributed to this report.

Sea turtle rehab center closes at Gumbo Limbo
Sea turtle rehab center closes at Gumbo Limbo

Yahoo

time21 minutes ago

  • Yahoo

Sea turtle rehab center closes at Gumbo Limbo

BOCA RATON — The Sea Turtle Rehabilitation Center at the Gumbo Limbo Nature Center has been closed, the nonprofit operating the turtle hospital announced Friday. The Coastal Stewards said in a news release it was closing the center for financial reasons. 'Like many environmental nonprofits, The Coastal Stewards has faced increasing difficulty securing consistent and sustainable funding,' said Shivani Gupta, Board of Trustee member at The Coastal Stewards, in a prepared statement. 'This difficult decision allows us to reallocate resources and focus on our long-standing commitment to marine conservation education and empowering the next generation of ocean advocates.' The gift shop at the center also has been closed, Coastal Stewards said. The 13 sea turtle patients currently being treated at Gumbo Limbo are receiving veterinary care and will be transferred to other licensed sea turtle rehabilitation facilities when they become available, the nonprofit said, adding that it is working with the Florida Fish and Wildlife Conservation Commission during this process. The three resident sea turtles in tanks at the Gumbo Limbo center remain on view for the public, Coastal Stewards said. The center is operated by the city of Boca Raton. In a statement on its website announcing the closure of the rehab facility, the city said the center "remains fully open and active. The Center will continue its conservation and education efforts, including its sea turtle nesting and hatchling programs, youth camps, community education and other popular visitor attractions." The city said it is "open to exploring partnerships with other qualified nonprofit organizations that may be interested in continuing sea turtle rehabilitation on-site and will determine the best use of the gift shop space." This article originally appeared on Palm Beach Post: Sea turtle rehab center at Boca's Gumbo Limbo closes

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store